Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2015, Article ID 856931, 4 pages
http://dx.doi.org/10.1155/2015/856931
Case Report

Triple Negative Breast Cancer in Pregnancy and Postpartum: Two Case Reports in Hispanic Women

1Department of Obstetrics and Gynecology, Lincoln Medical and Mental Health Center, Bronx, NY 10451, USA
2Department of Surgery, Lincoln Medical and Mental Health Center, Bronx, NY 10451, USA

Received 27 July 2015; Accepted 24 August 2015

Academic Editor: Giampiero Capobianco

Copyright © 2015 Ruchi Upadhyay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Molckovsky and Y. Madarnas, “Breast cancer in pregnancy: a literature review,” Breast Cancer Research and Treatment, vol. 108, no. 3, pp. 333–338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Mathelin, K. Annane, A. Treisser et al., “Pregnancy and post-partum breast cancer: a prospective study,” Anticancer Research, vol. 28, no. 4, pp. 2447–2452, 2008. View at Google Scholar · View at Scopus
  3. R. Prosperi Porta, D. Montruccoli-Salmi, M. Lalle et al., “Pregnancy-associated breast cancer,” European Journal of Gynaecological Oncology, vol. 19, no. 4, pp. 401–404, 1998. View at Google Scholar · View at Scopus
  4. F. Schnabel, J. Billig, A. Cimeno, and J. Chun, “Pregnancy-associated breast cancer and increased risk of pregnancy-associated recurrence: a case report,” Journal of Medical Case Reports, vol. 6, article 144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Krishna and M. Lindsay, “Breast cancer in pregnancy,” Obstetrics & Gynecology Clinics of North America, vol. 40, no. 3, pp. 559–571, 2013. View at Google Scholar
  6. J. Fornetti, H. Martinson, V. Borges, and P. Schedin, “Emerging targets for the prevention of pregnancy-associated breast cancer,” Cell Cycle, vol. 11, no. 4, pp. 639–640, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Schedin, “Pregnancy-associated breast cancer and metastasis,” Nature Reviews Cancer, vol. 6, no. 4, pp. 281–291, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A.-S. Genin, M. Antoine, S. Aractingi, and R. Rouzier, “Pregnancy stimulates tumor angiogenesis in breast carcinoma,” Anticancer Research, vol. 34, no. 1, pp. 125–131, 2014. View at Google Scholar · View at Scopus
  9. S. Swain, “Triple-negative breast cancer: metastatic risk and role of platinum agents,” in Proceedings of the ASCO Clinical Science Symposium, Chicago, Ill, USA, June 2008.
  10. A. I. Phipps, R. T. Chlebowski, R. Prentice et al., “Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer,” Journal of the National Cancer Institute, vol. 103, no. 6, pp. 470–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Lara-Medina, V. Pérez-Sánchez, D. Saavedra-Pérez et al., “Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity,” Cancer, vol. 117, no. 16, pp. 3658–3669, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Lee, R. McKean-Cowdin, H. Ma et al., “Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women,” Journal of Clinical Oncology, vol. 29, no. 33, pp. 4373–4380, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Dent, M. Trudeau, K. I. Pritchard et al., “Triple-negative breast cancer: clinical features and patterns of recurrence,” Clinical Cancer Research, vol. 13, no. 15, part 1, pp. 4429–4434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. N. U. Lin, E. Claus, J. Sohl, A. R. Razzak, A. Arnaout, and E. P. Winer, “Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases,” Cancer, vol. 113, no. 10, pp. 2638–2645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Cohn, B. Ramaswamy, and K. Blum, “Malignancy and pregnancy,” in Maternal-Fetal Medicine Principles and Practice, R. Creasy, J. Iams, and R. Resnik, Eds., pp. 885–904, WB Saunders, Toronto, Canada, 6th edition, 2010. View at Google Scholar
  16. J. K. Litton and R. L. Theriault, “Breast cancer and pregnancy: current concepts in diagnosis and treatment,” Oncologist, vol. 15, no. 12, pp. 1238–1247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Amant, S. Loibl, P. Neven, and K. Van Calsteren, “Breast cancer in pregnancy,” The Lancet, vol. 379, no. 9815, pp. 570–579, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Gentilini, M. Cremonesi, A. Toesca et al., “Sentinel lymph node biopsy in pregnant patients with breast cancer,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 1, pp. 78–83, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. Jones, “Management of pregnancy-associated breast cancer,” The Breast, vol. 15, supplement 2, pp. S47–S52, 2006, Erratum in: The Breast, vol. 17, no. 2, p. 213, 2008. View at Publisher · View at Google Scholar
  20. P. G. Duncan, W. D. B. Pope, M. M. Cohen, and N. Greer, “Fetal risk of anesthesia and surgery during pregnancy,” Anesthesiology, vol. 64, no. 6, pp. 790–794, 1986. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Amant, S. Deckers, K. Van Calsteren et al., “Breast cancer in pregnancy: recommendations of an international consensus meeting,” European Journal of Cancer, vol. 46, no. 18, pp. 3158–3168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. A. Ali, S. Gupta, R. Sehgal, and V. Vogel, “Survival outcomes in pregnancy associated breast cancer: a retrospective case control study,” Breast Journal, vol. 18, no. 2, pp. 139–144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. H. A. Azim Jr., L. Santoro, W. Russell-Edu, G. Pentheroudakis, N. Pavlidis, and F. A. Peccatori, “Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies,” Cancer Treatment Reviews, vol. 38, no. 7, pp. 834–842, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Amant, G. von Minckwitz, S. N. Han et al., “Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study,” Journal of Clinical Oncology, vol. 31, no. 20, pp. 2532–2539, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Amant, K. Van Calsteren, M. J. Halaska et al., “Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study,” The Lancet Oncology, vol. 13, no. 3, pp. 256–264, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Loibl, S. N. Han, G. von Minckwitz et al., “Treatment of breast cancer during pregnancy: an observational study,” The Lancet Oncology, vol. 13, no. 9, pp. 887–896, 2012. View at Publisher · View at Google Scholar · View at Scopus